CTLA4 and cancer: Tumor suppression of T-cell activation via PD-1 and/or CTLA-4 is a major escape mechanism of cancer cells, and the possibility of unlocking this suppression revolutionized the treatment paradigm of many types of cancer, including SCCHN.